CPhI South East Asia Gathers March 22–24 in Jakarta
South East Asian pharma manufacturers seeking region growth expected to attend CPhi South East Asia.
CPhI South East Asia returns to the Jakarta International Expo in Indonesia for its sixth edition from March 22–24, 2017 as regional pharma companies expect robust growth. Favorable macro trends are encouraging domestic manufacturers are increasingly attending the event, with a view to opening sales in international markets, the event organizers report.
South East Asian (SEA) pharmaceutical manufacturers are shifting focus regional exports due to a slowing pace of global markets and increased threat of protectionist wave. In addition, international investors and companies are looking at more business access in Indonesia and across the regional economy. For example, Indonesia is home to 25–30 generic domestic companies with access to the international market, and approximately 35 multinational companies, such as Sanofi, ACG and Novo Nordisk are established in the area. The remaining 125–135 domestic manufacturers, which are increasing targeting international sales in neighboring countries, according to CPhI reports.
CPhI South East Asia will gather more than 5500 attendees from 41 countries and more than 260 exhibitors to network, learn, and conduct business. Co-located with P-MEC, InnoPack, ICSE, and Health Ingredients South East Asia, the event hosts pharma ingredients professionals, packaging experts, machinery providers, contract manufacturing, and nutraceutical companies from the region.
A conference program will cover business outlook and markets, regulations and compliance, and manufacturing and supply chain. Sessions include strategies to improve market access, compliance strategies when managing third parties, Big Data trends and applications in supply chain, the pharmaceutical industry in South East Asia, and ASEAN regulatory harmonization developments.
The event is supported by the national and regional governments and regional trade groups, including the Ministry of Health, Ministry of Industry, Indonesia Investment Coordinating Board, and the National Agency for Drug and Food Control.
Special events include an investment forum, ASEAN-India strategic sourcing forum, a distributor network, and business matchmaking program.
Editor’s Note: CPhI and Pharmaceutical Technology are UBM plc brands.
Source: CPhI South East Asia
Texas' MD Anderson Cancer Center Creates New Cell Therapy Institute
November 11th 2024With the launch of the Institute for Cell Therapy Discovery and Innovation, the MD Anderson Cancer Center will bring together expertise in developing cell therapies for cancer, autoimmune diseases, and infections.
